------------------------ Yahoo! Groups Sponsor --------------------~-->
Get fast access to your favorite Yahoo! Groups. Make Yahoo! your home page
http://us.click.yahoo.com/dpRU5A/wUILAA/yQLSAA/H4xqlB/TM
--------------------------------------------------------------------~->
Oncolytics Biotech's Research Collaborators to Present Data on
REOLYSIN(R) Research at AACR-NCI-EORTC Conference
CALGARY, Oct. 5 - Oncolytics Biotech Inc.
("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that
presentations
covering various REOLYSIN(R) research programs will be made at the
AACR-NCI-EORTC International Conference on Molecular Targets and
Cancer
Therapeutics: Discovery, Biology, and Clinical Applications, to be
held
November 14 to 18 in Philadelphia, Pennsylvania. A poster
entitled 'A Phase I
study of a wild-type reovirus (Reolysin) given intravenously to
patients with
advanced malignancies' will be presented by Dr. Johann S. de Bono of
The Royal
Marsden Hospital and The Institute of Cancer Research, UK, and a
poster
entitled 'Reovirus enhances radiation cytotoxicity in vitro and in
vivo' will
be presented by Dr. Kevin J. Harrington of the Targeted Therapy
Laboratory,
The Institute of Cancer Research, Cancer Research UK Centre for Cell
and
Molecular Biology, UK.
About Oncolytics Biotech Inc.
Oncolytics is a Calgary-based biotechnology company focused on
the
development of REOLYSIN(R), its proprietary formulation of the human
reovirus,
as a potential cancer therapeutic. Oncolytics' researchers have
demonstrated
that the reovirus is able to selectively kill cancer cells and, in
vitro, kill
human cancer cells that are derived from many types of cancer
including
breast, bladder, prostate, pancreatic and brain tumours, and have
also
demonstrated successful cancer treatment results in a number of
animal models.
Phase I clinical trial results have indicated that REOLYSIN(R) was
well
tolerated and that the reovirus demonstrated activity in tumours
injected with
REOLYSIN(R).
This press release contains forward-looking statements, within
the
meaning of Section 21E of the Securities Exchange Act of 1934, as
amended.
Forward-looking statements, including the implication of the
materials
presented at this conference with respect to REOLYSIN(R), the
Company's
expectations related to the results of the Phase I/II trials
investigating
delivery of REOLYSIN(R), and the Company's belief as to the
potential of
REOLYSIN(R) as a cancer therapeutic, involve known and unknown risks
and
uncertainties, which could cause the Company's actual results to
differ
materially from those in the forward-looking statements. Such risks
and
uncertainties include, among others, the availability of funds and
resources
to pursue research and development projects, the efficacy of REOLYSIN
(R) as a
cancer treatment, the success and timely completion of clinical
studies and
trials, the Company's ability to successfully commercialize REOLYSIN
(R),
uncertainties related to the research and development of
pharmaceuticals,
uncertainties related to the regulatory process and general changes
to the
economic environment. Investors should consult the Company's
quarterly and
annual filings with the Canadian and U.S. securities commissions for
additional information on risks and uncertainties relating to the
forward-looking statements. Investors are cautioned against placing
undue
reliance on forward-looking statements. The Company does not
undertake to
update these forward-looking statements.
SOURCE Oncolytics Biotech Inc.
http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/
http://www.arizonabiotech.com/index.php
http://www.mail-archive.com/biotech-news@yahoogroups.com/
http://www.mail-archive.com/biotech-
[EMAIL PROTECTED]/maillist.html
http://www.arizonabiotech.com/
<a href="http://www.arizonabiotech.com/";>Arizona Biotech</a>
http://groups.yahoo.com/group/biotech-news/
<a href="http://groups.yahoo.com/group/biotech-news/";>Biotech News</a>
http://www.arizonaentrepreneurs.com/
<a href="http://www.arizonaentrepreneurs.com/";>Arizona Entrepreneurs</a>
http://www.azhttp.com/
<a href="http://www.azhttp.com/";>Arizona High Tech</a>
Yahoo! Groups Links
<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/
<*> To unsubscribe from this group, send an email to:
[EMAIL PROTECTED]
<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/
